Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial

References

• Keys HM, Bundy BN, Stehman FB, et al. (1999). Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–61.
   PubMed Web of Science ®Google Scholar
• Morris M, Eifel PJ, Lu J, et al. (1999). Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–43.
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, et al. (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–53.
   PubMed Web of Science ®Google Scholar
• Datta NR, Rogers S, Klingbiel D, et al. (2016). Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses. Int J Hyperthermia 32:809–21.
   PubMed Web of Science ®Google Scholar
• Datta NR, Puric E, Klingbiel D, et al. (2016). Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 94:1073–87.
   PubMed Web of Science ®Google Scholar
• Cihoric N, Tsikkinis A, van Rhoon G, et al. (2015). Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia 31:609–14.
   PubMed Web of Science ®Google Scholar
• Longo TA, Gopalakrishna A, Tsivian M, et al. (2016). A systematic review of regional hyperthermia therapy in bladder cancer. Int J Hyperthermia 32:381–9.
   PubMed Web of Science ®Google Scholar
• Sousa A, Pineiro I, Rodriguez S, et al. (2016). Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer. Int. J Hyperthermia 32:374–80.
   PubMed Web of Science ®Google Scholar
• Datta NR, Rogers S, Ordonez SG, et al. (2016). Hyperthermia and radiotherapy in the management of head and neck cancers: a systematic review and meta-analysis. Int J Hyperthermia 32:31–40.
   PubMed Web of Science ®Google Scholar
• Jones EL, Samulski TV, Leonard RP, Dewhirst MW. (2003). Hyperthermia, 4th ed. Philadelphia: Lippincott Williams & Wilkins,.
   Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, et al. (2000). Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119–25.
   PubMed Web of Science ®Google Scholar
• Ben-Hur E, Elkind MM. (1974). Thermally enhanced radioresponse of cultured Chinese hamster cells: damage and repair of single-stranded DNA and a DNA complex. Radiat Res 59:484–95.
   PubMed Web of Science ®Google Scholar
• Krawczyk PM, Eppink B, Essers J, et al. (2011). Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci U S A 108:9851–6.
   PubMed Web of Science ®Google Scholar
• Issels R, Kampmann E, Kanaar R, Lindner LH. (2016). Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application. Int J Hyperthermia 32:89–95.
   PubMed Web of Science ®Google Scholar
• Oei AL, Vriend LE, Crezee J, et al. (2015). Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol 10:165
   PubMed Web of Science ®Google Scholar
• Horsman MR, Overgaard J. (2007). Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 19:418–26.
   PubMed Web of Science ®Google Scholar
• Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. (1977). Cellular responses to combinations of hyperthermia and radiation. Radiology 123:463–74.
   PubMed Web of Science ®Google Scholar
• Sapareto SA, Hopwood LE, Dewey WC. (1978). Combined effects of X irradiation and hyperthermia on CHO cells for various temperatures and orders of application. Radiat Res 73:221–33.
   PubMed Web of Science ®Google Scholar
• van Rhoon GC. (2016). Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring? Int J Hyperthermia 32:50–62.
   PubMed Web of Science ®Google Scholar
• Sherar M, Liu FF, Pintilie M, et al. (1997). Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys 39:371–80.
   PubMed Web of Science ®Google Scholar
• Franckena M, Fatehi D, de Bruijne M, et al. (2009). Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 45:1969–78.
   PubMed Web of Science ®Google Scholar
• Rau B, Wust P, Tilly W, et al. (2000). Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 48:381–91.
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Yahara K, et al. (2009). Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes. Int. J Radiat Oncol Biol Phys 73:128–35.
   PubMed Web of Science ®Google Scholar
• Yahara K, Ohguri T, Yamaguchi S, et al. (2015). Definitive radiotherapy plus regional hyperthermia for high-risk and very high-risk prostate carcinoma: thermal parameters correlated with biochemical relapse-free survival. Int J Hyperthermia 31:600–8.
   PubMed Web of Science ®Google Scholar
• Harima Y, Ohguri T, Imada H, et al. (2016). A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. Int J Hyperthermia 32:801–8.
   PubMed Web of Science ®Google Scholar
• Sreenivasa G, Hildebrandt B, Kummel S, et al. (2006). Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or = FIGO IIB “bulky”. Int J Radiat Oncol Biol Phys 66:1159–67.
   PubMed Web of Science ®Google Scholar
• Song CW, Rhee JG, Lee CK, Levitt SH. (1986). Capacitive heating of phantom and human tumors with an 8 MHz radiofrequency applicator (Thermotron RF-8). Int J Radiat Oncol Biol Phys 12:365–72.
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Jo S, Akuta K, et al. (1987). Radiofrequency capacitive hyperthermia for deep-seated tumors. I. Studies on thermometry. Cancer 60:121–7.
   PubMed Web of Science ®Google Scholar
• Abe M, Hiraoka M, Takahashi M, et al. (1986). Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 58:1589–95.
   PubMed Web of Science ®Google Scholar
• Fatehi D, van der Zee J, Notenboom A, van Rhoon GC. (2007). Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors. Strahlenther Onkol 183:479–86.
   PubMed Web of Science ®Google Scholar
• Oleson JR, Samulski TV, Leopold KA, et al. (1993). Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 25:289–97.
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, et al. (2005). Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–85.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Viglianti BL, Lora-Michiels M, et al. (2003). Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 19:267–94.
   PubMed Web of Science ®Google Scholar
• Trotti A, Byhardt R, Stetz J, et al. (2000). Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47:13–47.
   PubMed Web of Science ®Google Scholar
• Triantopoulou S, Efstathopoulos E, Platoni K, et al. (2013). Radiotherapy in conjunction with superficial and intracavitary hyperthermia for the treatment of solid tumors: survival and thermal parameters. Clin Transl Oncol 15:95–105.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, et al. (1995). Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 345:540–3.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Sim DA, Sapareto S, Connor WG. (1984). Importance of minimum tumor temperature in determining early and long-term responses of spontaneous canine and feline tumors to heat and radiation. Cancer Res 44:43–50.
   PubMed Web of Science ®Google Scholar
• Thrall DE, LaRue SM, Yu D, et al. (2005). Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 11:5206–14.
   PubMed Web of Science ®Google Scholar
• Kroeze H, van de Kamer JB, de Leeuw AA, et al. (2003). Treatment planning for capacitive regional hyperthermia. Int J Hyperthermia 19:58–73.
   PubMed Web of Science ®Google Scholar
• Ohguri T, Yahara K, Moon SD, et al. (2011). Deep regional hyperthermia for the whole thoracic region using 8 MHz radiofrequency-capacitive heating device: relationship between the radiofrequency-output power and the intra-oesophageal temperature and predictive factors for a good heating in 59 patients. Int J Hyperthermia 27:20–6.
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim YT, Kim S, et al. (2015). Prognosis of cervical cancer in the era of concurrent chemoradiation from national database in Korea: a comparison between squamous cell carcinoma and adenocarcinoma. PLoS One 10:e0144887.
   PubMed Web of Science ®Google Scholar
• Rose PG, Java JJ, Whitney CW, et al. (2014). Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation. Gynecol Oncol 135:208–12.
   PubMed Web of Science ®Google Scholar
• Parker K, Gallop-Evans E, Hanna L, Adams M. (2009). Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution. Int J Radiat Oncol Biol Phys 74:140–6.
   PubMed Web of Science ®Google Scholar
• Nugent EK, Case AS, Hoff JT, et al. (2010). Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. Gynecol Oncol 116:438–41.
   PubMed Web of Science ®Google Scholar